72 related articles for article (PubMed ID: 8848002)
1. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
Buck KJ; Amara SG
Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
[TBL] [Abstract][Full Text] [Related]
2. Transporters involved in adult rat cortical astrocyte dopamine uptake: Kinetics, expression and pharmacological modulation.
Sočan V; Dolinar K; Kržan M
Eur J Neurosci; 2024 Mar; 59(6):1296-1310. PubMed ID: 38054361
[TBL] [Abstract][Full Text] [Related]
3. Structure Modeling of the Norepinephrine Transporter.
Góral I; Łątka K; Bajda M
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936154
[TBL] [Abstract][Full Text] [Related]
4. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
Penmatsa A; Wang KH; Gouaux E
Nat Struct Mol Biol; 2015 Jun; 22(6):506-508. PubMed ID: 25961798
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters.
Pidathala S; Mallela AK; Joseph D; Penmatsa A
Nat Commun; 2021 Apr; 12(1):2199. PubMed ID: 33850134
[TBL] [Abstract][Full Text] [Related]
6. Chiral Resolution of the Enantiomers of the Slow-Onset Dopamine Reuptake Inhibitor CTDP-32476 and Their Activities.
Froimowitz M; Taboada R; Poulos ZJ; Rainone DJ; Imler GH; Gardner EL; Kelley CJ
ACS Omega; 2023 Oct; 8(39):35738-35745. PubMed ID: 37810691
[TBL] [Abstract][Full Text] [Related]
7. Monoamine transporters: vulnerable and vital doorkeepers.
Lin Z; Canales JJ; Björgvinsson T; Thomsen M; Qu H; Liu QR; Torres GE; Caine SB
Prog Mol Biol Transl Sci; 2011; 98():1-46. PubMed ID: 21199769
[TBL] [Abstract][Full Text] [Related]
8. The "www" of
Bhatt M; Di Iacovo A; Romanazzi T; Roseti C; Cinquetti R; Bossi E
Membranes (Basel); 2022 Sep; 12(10):. PubMed ID: 36295686
[TBL] [Abstract][Full Text] [Related]
9. Critical Role of Oxidatively Damaged DNA in Selective Noradrenergic Vulnerability.
Zhan Y; Raza MU; Yuan L; Zhu MY
Neuroscience; 2019 Dec; 422():184-201. PubMed ID: 31698021
[TBL] [Abstract][Full Text] [Related]
10. Classic Studies on the Interaction of Cocaine and the Dopamine Transporter.
Verma V
Clin Psychopharmacol Neurosci; 2015 Dec; 13(3):227-38. PubMed ID: 26598579
[TBL] [Abstract][Full Text] [Related]
11. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter.
Andersen J; Ringsted KB; Bang-Andersen B; Strømgaard K; Kristensen AS
Sci Rep; 2015 Oct; 5():15650. PubMed ID: 26503701
[TBL] [Abstract][Full Text] [Related]
12. Drug elucidation: invertebrate genetics sheds new light on the molecular targets of CNS drugs.
Dwyer DS; Aamodt E; Cohen B; Buttner EA
Front Pharmacol; 2014; 5():177. PubMed ID: 25120487
[TBL] [Abstract][Full Text] [Related]
13. X-ray structure of dopamine transporter elucidates antidepressant mechanism.
Penmatsa A; Wang KH; Gouaux E
Nature; 2013 Nov; 503(7474):85-90. PubMed ID: 24037379
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants for selective recognition of antidepressants in the human serotonin and norepinephrine transporters.
Andersen J; Stuhr-Hansen N; Zachariassen L; Toubro S; Hansen SM; Eildal JN; Bond AD; Bøgesø KP; Bang-Andersen B; Kristensen AS; Strømgaard K
Proc Natl Acad Sci U S A; 2011 Jul; 108(29):12137-42. PubMed ID: 21730142
[TBL] [Abstract][Full Text] [Related]
15. Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.
Surratt CK; Ukairo OT; Ramanujapuram S
AAPS J; 2005 Oct; 7(3):E739-51. PubMed ID: 16353950
[TBL] [Abstract][Full Text] [Related]
16. Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.
Selz KA; Mandell AJ; Shlesinger MF; Arcuragi V; Owens MJ
Biophys J; 2004 Mar; 86(3):1308-31. PubMed ID: 14990463
[TBL] [Abstract][Full Text] [Related]
17. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.
Hahn MK; Robertson D; Blakely RD
J Neurosci; 2003 Jun; 23(11):4470-8. PubMed ID: 12805287
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the NH2 terminal domain of catecholamine transporters in the Na(2+) and Cl(-)-dependence of a [3H]-dopamine uptake.
Syringas M; Janin F; Giros B; Costentin J; Bonnet JJ
Br J Pharmacol; 2001 Jun; 133(3):387-94. PubMed ID: 11375255
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide mediated modulation of norepinephrine transport: identification of a potential target for S-nitrosylation.
Kaye DM; Gruskin S; Smith AI; Esler MD
Br J Pharmacol; 2000 Jul; 130(5):1060-4. PubMed ID: 10882390
[TBL] [Abstract][Full Text] [Related]
20. Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake.
Galli A; Blakely RD; DeFelice LJ
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13260-5. PubMed ID: 9789076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
